Nat Med 7(9):987989 Jayson GC, Hicklin DJ, Ellis LM (2012) Antiangiogenic therapyevolving view based on clinical trial results
In Parkinson's disease, however, glutathione may theoretically help slow the disease by reducing the oxidative stress that damages dopamine neurons
Individuals taking medications, managing health conditions, or who are pregnant or nursing are appropriately evaluated by qualified healthcare professionals when considering GLP-1 medications
The primary information has been curated from the literature and consists of the following major fields namely: (i) PMID, (ii) the peptide sequence, (iii) the name of peptide, (iv) the length of peptide, (v) N-terminal modification, (vi) C-terminal modification (vii) configuration (linear or cyclic) (viii) chirality of the amino acids, (ix) chemical modification, (x) origin of the peptide, (xi) biological activity of the peptide, (xii) half-life, (xiii) assay types, (xiv) sample on which the half-life was tested and (xv) Patent ID
